GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Book Value per Share

OKUR (OnKure Therapeutics) Book Value per Share : $7.78 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OnKure Therapeutics Book Value per Share?

OnKure Therapeutics's book value per share for the quarter that ended in Dec. 2024 was $7.78.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

OnKure Therapeutics's current price is $2.50. Its book value per share for the quarter that ended in Dec. 2024 was $7.78. Hence, today's PB Ratio of OnKure Therapeutics is 0.32.

During the past 3 years, the highest P/B Ratio of OnKure Therapeutics was 0.32. The lowest was 0.00. And the median was 0.00.


OnKure Therapeutics Book Value per Share Historical Data

The historical data trend for OnKure Therapeutics's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OnKure Therapeutics Book Value per Share Chart

OnKure Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Book Value per Share
-4.08 -7.64 7.78

OnKure Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Book Value per Share Get a 7-Day Free Trial Premium Member Only -7.64 -8.34 -9.26 5.55 7.78

Competitive Comparison of OnKure Therapeutics's Book Value per Share

For the Biotechnology subindustry, OnKure Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OnKure Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OnKure Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where OnKure Therapeutics's PB Ratio falls into.


;
;

OnKure Therapeutics Book Value per Share Calculation

OnKure Therapeutics's Book Value Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(103.83-0.00)/13.35
=7.78

OnKure Therapeutics's Book Value Per Share for the quarter that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(103.83-0.00)/13.35
=7.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


OnKure Therapeutics  (NAS:OKUR) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


OnKure Therapeutics Book Value per Share Related Terms

Thank you for viewing the detailed overview of OnKure Therapeutics's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


OnKure Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.